Developing and Characterization of Chemically Modified RNA Aptamers for Targeting Wild Type and Mutated c-KIT Receptor Tyrosine Kinases
Ala’a S. Shraim(University of Jordan), Said I. Ismail(Qatar Foundation), Nidaa A. Ababneh(University of Jordan), Abdelrahim A. Hunaiti(University of Jordan), Abdalla Awidi(University of Jordan), Bashaer Abu‐Irmaileh(University of Jordan), Fadwa Odeh(University of Jordan), Walhan Alshaer(Al-Ahliyya Amman University)
Cited by 9
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease
|Cell Genomics|2022|422
Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
|Molecules|2019|396
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141